Richard C Dodel

Summary

Affiliation: University of Bonn
Country: Germany

Publications

  1. ncbi request reprint Immunotherapy for Alzheimer's disease
    Richard C Dodel
    Department of Neurology, Friedrich Wilhelms University Bonn, Germany
    Lancet Neurol 2:215-20. 2003
  2. ncbi request reprint An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease
    Candan Depboylu
    Department of Neurology, Rheinische Friedrich Wilhelms University Bonn, Bonn, Germany
    Dement Geriatr Cogn Disord 17:170-3. 2004
  3. ncbi request reprint The socioeconomic impact of narcolepsy
    Richard Dodel
    Department of Neurology, Friedrich Wilhelms University Bonn, Germany
    Sleep 27:1123-8. 2004
  4. pmc Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease
    R C Dodel
    Department of Neurology, Friedrich Wilhelms University, Sigmund Freudstr 25, 53105 Bonn, Germany
    J Neurol Neurosurg Psychiatry 75:1472-4. 2004
  5. ncbi request reprint Resource utilization and costs of stroke unit care in Germany
    Richard C Dodel
    Department of Neurology and Institute of Medical Biometry and Epidemiology, Philipps University, Marburg, Marburg, Germany
    Value Health 7:144-52. 2004
  6. ncbi request reprint Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach
    Richard C Dodel
    Department of Neurology, Friedrich Wilhelms University, Bonn, Germany
    Mov Disord 18:S52-62. 2003
  7. ncbi request reprint Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease
    Candan Depboylu
    Department of Neurology, Philipps University Marburg, Rudolph Bultmann Str 8, 35039 Marburg, Germany
    Neurosci Lett 400:187-90. 2006
  8. ncbi request reprint Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's disease
    Jens Carsten Moller
    Department of Neurology, Philipps University, Marburg, Germany
    Neurosci Lett 359:195-7. 2004
  9. ncbi request reprint The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice
    Vanessa Stuckenholz
    Department of Neurology, Philipps University of Marburg, Baldingerstrasse, Marburg, Germany
    J Parkinsons Dis 3:161-72. 2013
  10. doi request reprint Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's disease
    Carmen Noelker
    Department of Neurology, Philipps University Marburg, Germany
    Neurosci Lett 507:10-5. 2012

Collaborators

Detail Information

Publications17

  1. ncbi request reprint Immunotherapy for Alzheimer's disease
    Richard C Dodel
    Department of Neurology, Friedrich Wilhelms University Bonn, Germany
    Lancet Neurol 2:215-20. 2003
    ..This review focuses on immunisation strategies and details of the pathways involved in antibody clearance of Abeta...
  2. ncbi request reprint An interleukin-6 promoter variant is not associated with an increased risk for Alzheimer's disease
    Candan Depboylu
    Department of Neurology, Rheinische Friedrich Wilhelms University Bonn, Bonn, Germany
    Dement Geriatr Cogn Disord 17:170-3. 2004
    ..No evidence of an earlier age at onset for carriers of the C allele was evaluated. We conclude that IL-6 (-174) polymorphism does not influence the risk of developing AD in our cohort...
  3. ncbi request reprint The socioeconomic impact of narcolepsy
    Richard Dodel
    Department of Neurology, Friedrich Wilhelms University Bonn, Germany
    Sleep 27:1123-8. 2004
    ..To evaluate the economic burden of patients suffering from narcolepsy...
  4. pmc Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease
    R C Dodel
    Department of Neurology, Friedrich Wilhelms University, Sigmund Freudstr 25, 53105 Bonn, Germany
    J Neurol Neurosurg Psychiatry 75:1472-4. 2004
    ..This study reports the results from a pilot study using IVIgG in patients with AD...
  5. ncbi request reprint Resource utilization and costs of stroke unit care in Germany
    Richard C Dodel
    Department of Neurology and Institute of Medical Biometry and Epidemiology, Philipps University, Marburg, Marburg, Germany
    Value Health 7:144-52. 2004
    ..Recently, the concept of an integrated stroke unit has been established in several countries to improve the outcome of patients. This study evaluates the costs of acute care of the different cerebrovascular insults in a stroke unit...
  6. ncbi request reprint Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach
    Richard C Dodel
    Department of Neurology, Friedrich Wilhelms University, Bonn, Germany
    Mov Disord 18:S52-62. 2003
    ..These results should be adjusted to the specific setting and individual patient preferences...
  7. ncbi request reprint Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease
    Candan Depboylu
    Department of Neurology, Philipps University Marburg, Rudolph Bultmann Str 8, 35039 Marburg, Germany
    Neurosci Lett 400:187-90. 2006
    ..Although LRP as well as RAP seem to play an essential role in the metabolism of alpha2M and APOE, there is no increase in the genetic risk for AD in patients carrying the investigated polymorphisms...
  8. ncbi request reprint Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson's disease
    Jens Carsten Moller
    Department of Neurology, Philipps University, Marburg, Germany
    Neurosci Lett 359:195-7. 2004
    ..We conclude that the C/T polymorphism in the IL-1alpha promoter region at -889 does not increase the risk to develop PD...
  9. ncbi request reprint The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice
    Vanessa Stuckenholz
    Department of Neurology, Philipps University of Marburg, Baldingerstrasse, Marburg, Germany
    J Parkinsons Dis 3:161-72. 2013
    ..A major component of this pathway is the α7 nicotinic acetylcholine receptor (α7 nACh receptor), which is expressed on immune cells such as microglia...
  10. doi request reprint Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's disease
    Carmen Noelker
    Department of Neurology, Philipps University Marburg, Germany
    Neurosci Lett 507:10-5. 2012
    ..Further studies will be necessary on the physiological role of the identified proteins and their impact on pathways leading to neurodegeneration in PD...
  11. ncbi request reprint Role of dopamine transporter SPECT for the practitioner and the general neurologist
    Wolfgang H Oertel
    Department of Neurology, Philipps University Marburg, Germany
    Mov Disord 18:S9-15. 2003
    ..Future studies must clarify whether it is cost effective to generously perform dopamine transporter SPECTs to minimize the time until parkinsonism can be diagnosed...
  12. ncbi request reprint Lack of association of interleukin-10 promoter region polymorphisms with Alzheimer's disease
    Candan Depboylu
    Department of Neurology, Friedrich Wilhelms University, Sigmund Freud Strasse 25, 53105, Bonn, Germany
    Neurosci Lett 342:132-4. 2003
    ..We conclude that polymorphisms in the IL-10 promoter region do not increase the risk of developing AD...
  13. ncbi request reprint Health-related quality of life and economic burden in patients with restless legs syndrome
    Jens P Reese
    Philipps University Marburg, Department of Neurology, Rudolf Bultmannstr 8, 35039 Marburg, Germany
    Expert Rev Pharmacoecon Outcomes Res 7:503-21. 2007
    ..Very few of the RLS treatment options, however, have been evaluated for their cost-effectiveness, and further research is needed on both quality-of-life issues and the economic impact of RLS...
  14. ncbi request reprint A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD
    R C Dodel
    Department of Neurology, Philipps University Marburg, Germany
    Neurology 58:664. 2002
  15. ncbi request reprint Systematic assessment of decision models in Parkinson's disease
    Uwe Siebert
    Institute for Technology Assessment and Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Value Health 7:610-26. 2004
    ..To give an insight into the structural and methodological approaches used in published decision-analytic models evaluating interventions in Parkinson's disease (PD) and to derive recommendations for future comprehensive PD decision models...
  16. ncbi request reprint Cabergoline versus levodopa monotherapy: a decision analysis
    Antje M Smala
    Medical Economics Research Group MERG, Munich, Germany
    Mov Disord 18:898-905. 2003
    ..Although costs were higher in patients on cabergoline, the corresponding cost-effectiveness ratio for cabergoline was at least as favourable as the ratios for many commonly accepted therapies...
  17. ncbi request reprint NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line
    Feng Gao
    Department of Neurology, Indiana University School of Medicine, Indianapolis, IN 46285, USA
    Brain Res Mol Brain Res 105:108-14. 2002
    ..Our data suggest that attenuation of IL-1beta-induced alpha(2)M synthesis/release by blocking NF-kappaB activation may potentially be 'protective' against the development of late-onset AD...